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Background: Although non-invasive mechanical ventilation (NIV) is the gold standard
treatment for patients with acute exacerbation of COPD (AECOPD) developing respiratory
acidosis, failure rates still range from 5% to 40%. Recent studies have shown that the onset
of severe diaphragmatic dysfunction (DD) during AECOPD increases risk of NIV failure and
mortality in this subset of patients. Although the imbalance between the load and the
contractile capacity of inspiratory muscles seems the main cause of AECOPD-induced
hypercapnic respiratory failure, data regarding the influence of mechanical derangement on
DD in this acute phase are lacking. With this study, we investigate the impact of respiratory
mechanics on diaphragm function in AECOPD patients experiencing NIV failure.
Methods: Twelve AECOPD patients with respiratory acidosis admitted to the Respiratory
ICU of the University Hospital of Modena from 2017 to 2018 undergoing mechanical
ventilation (MV) due to NIV failure were enrolled. Static respiratory mechanics and end-
expiratory lung volume (EELV) were measured after 30 mins of volume control mode MV.
Subsequently, transdiaphragmatic pressure (Pdi) was calculated by means of a sniff maneu-
ver (Pdisniff) after 30 mins of spontaneous breathing trial. Linear regression analysis and
Pearson’s correlation coefficient served to assess associations.
Results: Average Pdisniff was 23.3 cmH2O (standard deviation 29 cmH2O) with 3 patients
presenting bilateral diaphragm palsy. Pdisniff was directly correlated with static lung ela-
stance (r=0.69, p=0.001) while inverse correlation was found with dynamic intrinsic PEEP
(r=−0.73, p=0.007). No significant correlation was found with static intrinsic PEEP (r=−0.55,
p=0.06), EELV (r=−0.4, p=0.3), airway resistance (r=−0.2, p=0.54), chest wall, and total
elastance (r=−0-01, p=0.96 and r=0.3, p=0.36, respectively). Significant linear inverse
correlation was found between Pdisniff and the ratio between Pdi assessed at tidal volume
and Pdi sniff (r=−0.82, p=0.02).
Conclusion: The causes of extreme DD in AECOPD patients who experienced NIV failure
might be predominantly mechanical, driven by a severe dynamic hyperinflation that overlaps
on an elastic lung substrate favoring volume overload.
Keywords: acute exacerbation of COPD, non-invasive mechanical ventilation, respiratory
failure, transdiaphragmatic pressure
Introduction
Non-invasive mechanical ventilation (NIV) is the gold standard for the treatment of
patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD)
with respiratory acidosis.1 In this population, a considerable amount of data show that
NIV is able to reduce mortality and the need for tracheal intubation compared to standard
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medical therapy, although the failure rate ranges from 5% to
40% depending on the severity of respiratory failure.2 Recent
studies have shown that, among patients with severeAECOPD
admitted to an intensive care unit (ICU), 32% have severe
bilateral diaphragmatic dysfunction, which exposes them to
an increased risk of NIV failure and an almost fivefold higher
risk of dying.3,4 Although, during AECOPD, the imbalance
between the load and the contractile capacity of inspiratory
muscles is the main cause of hypercapnic respiratory failure,
data related to the maximal diaphragmatic force developed in
the acute phase are sparse.5–7 Some studies have investigated
the pressure-generating capacity of respiratory muscles during
AECOPD requiring NIV, demonstrating a reduction in the
force generated by the diaphragm with respect to the maximal
contractile capacity developed under conditions of clinical
stability.8,9 The reasons underlying the reduction in diaphragm
strength during exacerbation are not fully understood, although
several factors such as hyperinflation, systemic inflammation,
septic shock and sepsis, alterations in the biochemical environ-
ment (hypercapnia, acute respiratory acidosis, hypoxia), and
pharmacological factors (use of steroids) can contribute to this
result in various ways.10,11 Although it is known that lung
volume influences the contractile force of the diaphragm,
studies comparing the maximal force generated by the dia-
phragm with lung volume in the acute phase of AECOPD are
lacking.
Using a twitch tracheal pressure in response to mag-
netic phrenic nerve stimulation (Ptrstim), Demoule et al
have shown that 64% of the patients admitted to ICU
already have diaphragmatic dysfunction at the onset of
the critical illness, with sepsis as a major independent
risk factor.12 Therefore, since the pathophysiology
underlying AECOPD is extremely complex, the degree
of diaphragm dysfunction and the mechanisms involved
may be different from the “general” ICU population.
The main physiological factor related to a reduction in
diaphragm muscle strength during AECOPD is still
thought to be an altered force–volume relationship, due
to the phenomenon of hyperinflation, despite the fact
that, to our knowledge, no patients have so far demon-
strated this in vivo.
In the present study, we wanted to investigate this issue
in chronic obstructive pulmonary disease (COPD) patients
who had failed an NIV trial and therefore were intubated,
monitoring both transdiaphragmatic pressure during a sniff
maneuver and static and dynamic respiratory mechanics,
in order to verify a possible correlation.
Materials and Methods
This prospective physiological study was carried out in
a single respiratory intensive care unit (RICU) at the
University Hospital of Modena (Italy) over a 18-month
period (from January 2017 to June 2018). The study was
conducted according to the guidelines of the Declaration
of Helsinki. Approval from the local ethics committee of
Modena was obtained (registered protocol number 839/C.
E.). Written informed consent was obtained from each
patient before enrollment in the study. (NCT clinical-
trials.gov NCT03852394).
Patients
The eligibility criteria for the study were as follows: age over
18 years, AECOPD with respiratory acidosis admitted to the
RICU undergoing endotracheal intubation due to NIV fail-
ure. Exclusion criteria were any of the following: history of
neuromuscular disease, presence of chest wall deformities,
coexistence of interstitial lung disease, presence of pulmon-
ary edema, severe hemodynamic instability, septic shock,
evidence of lobar pneumonia or bilateral parenchymal con-
solidation at chest X-ray on admission, contraindication to
NIV, previously assessed diaphragmatic palsy, intracranial
hypertension, known pregnancy, need for immediate endo-
tracheal intubation, neurologic impairment, lack of colla-
boration, unreliable Pdisniff maneuver to calculate maximal
transdiaphragmatic pressure. Patients with sublobar consoli-
dation and signs of infection were classified as septic accord-
ing to the most recent consensus document.13
From January 2017 to June 2018, 130 patients with
AECOPD were admitted to the RICU for respiratory acidosis
requiring NIV. Forty-eight patients were considered non-
eligible due to the presence of exclusion criteria (Figure 1).
Out of 82 patients with AECOPD, 30 were eligible as they
experiencedNIV failure. Theywere intubated and subjected to
invasive ventilation. Propofol (2–3 mg/kg/hr) was the only
medication allowed for sedation of eligible patients. After 24
hrs of invasivemechanical ventilation, sedationwas suspended
once measurements of respiratory mechanical proprieties had
been performed. Enrollment criteria for patients after suspen-
sion of sedationwere established as follows: presence of stable
clinical conditions (no need for amine infusion, absence of
respiratory acidosis or severe hypercapnia [pCO2 < 60
mmHg], absence of major arrhythmias), absence of neurolo-
gical and cognitive deficits, GlasgowComa Scale of 15, ability
to tolerate a spontaneous breathing trial with T-tube for 30
mins, valid collaboration, Pdisniff deemed reliable after the
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execution of threemaximalmaneuvers. Eighteen patients were
excluded from the study due to the impossibility of performing
a reliable Pdisniff maneuver (Figure 1), while 12 patients were
included in the study and underwent the physiological analyses
required by the protocol.
Protocol
On admission, clinical severity was assessed with the Glasgow
Coma Scale (GCS), Kelly score, Acute Physiology and
Chronic Health Evaluation II (APACHE II) score, the
Simplified Acute Physiology Score (SAPS II) score, and the
Subsequent Organ Failure Assessment (SOFA) score. Arterial
blood gases (PaO2–PaCO2), pH, PaO2/FiO2 ratio, and blood
lactate levels were recorded before NIVand within 2 hrs after
NIV initiation. The presence of pneumonia,13 previous treat-
ment with systemic steroids, and relevant comorbidities were
also recorded. The diagnosis of COPD was confirmed by
clinical history and previous pulmonary function tests.
The baseline ventilatory settings were established by the
attending physician according to standard criteria: tidal
volume 6–8 mg/kg of ideal body weight, respiratory rate
12–15 breaths/min, positive end-expiratory pressure (PEEP)
6–8 cmH2O. In all patients, a multifunctional nasogastric tube
equipped with an esophageal and gastric balloon was placed
(NutriVent nasogastric polyfunctional catheter; SIDAM,
Mirandola, Italy), which was subsequently connected to
a pressure transducer (OptiVent monitor; SIDAM) to allow
the monitoring of esophageal (Pes) and gastric pressure (Pga).
An occlusion test was performed to assess the validity of Pes
measurements.14 The study protocol consisted of two conse-
cutive phases. Phase I was performed within 24 hrs of
mechanical ventilation in volume control mode with constant
inspiratory flow. In this first phase, measurements of static
respiratory mechanics were performed after 30 mins of zero
end-expiratory pressure (ZEEP). Phase II was performed after
stopping sedation during a spontaneous breathing trial with
T-tube, once the neurological, cognitive, and clinical
Figure 1 Flow chart for study population.
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conditions of the patient had been judged compatible with the
inclusion criteria (see above). In this phase, the physiological
measurements were performed 30 mins after initiation of the
spontaneous breathing trial.15
Physiologic Measurements
Flow (V’) was measured with a heated pneumotachograph
(Fleish2, Fleisch, Lausanne, Switzerland) placed between the
Y-piece of the ventilator and the artificial airway. Volume
was measured by integration of the flow. Airway pressure
(Paw) was measured proximally to the endotracheal tube.
The validity of the Pes and Pga measurements was assessed
with the methods described earlier. All traces were sampled
at 100 Hz and processed on a dedicated data acquisition
system (Colligo; Elekton, Milan, Italy). End-expiratory
lung volume (EELV)measurement was based on the nitrogen
washout/washin technique through dedicated software (FRC
Inview, GE Healthcare). The principle of this technique is as
follows: The volume of lung gas includes a volume of nitro-
gen (V(1)N2) that is determined by the alveolar fraction of
nitrogen (FAN2(1)) and by the EELV:
Vð1ÞN2¼FAN2ð1ÞEELV
The alveolar fraction of nitrogen can change by changing
the administered FiO2 (FAN2(2)), resulting in a new volume
of nitrogen (V(2)N2) in the lung after a period of balance.
Vð2ÞN2¼FAN2ð2ÞEELV
Assuming that, after the change of FiO2, the EELV does
not change until a new balance of the alveolar gas is
reached, the following equation can be written:
Vð1ÞN2Vð2ÞN2¼ FAN2ð2ÞFAN2ð1Þ
 EELV
As the changes in FAN2 mirror changes in FiO2, the EELV
can be calculated as:
EELV ¼ ΔN2 mLð Þ=ΔFiO2
where ΔN2 is equal to the exhaled nitrogen after the change
in FiO2 once equilibrium has been reached (20 breaths). The
algorithm used by the Engstrom Carestation (FRC Inview,
GE Healthcare) employs tidal concentration of oxygen and
carbon dioxide to obtain an estimate of nitrogen concentra-
tion in expired and inspired air. For more details, see Ref. 16.
Static respiratory mechanics and airway resistances were
calculated according to standard formulae.17,18 In phase I of
the study protocol, measurements of static respiratory
mechanics were performed using the end-inspiratory occlu-
sion (EIO) technique during constant flow inflation17 and the
end-expiratory occlusion (EEO) method.18 All patients were
studied in the semi-recumbent position and measurements
were performed after 30 mins of mechanical ventilation with
0 cmH2O of end-expiratory pressure (ZEEP).
In phase II of the study, transdiaphragmatic pressure (Pdi)
was calculated after a tidal inspiration. The maximal trans-
diaphragmatic pressure was calculated by a sniff maneuver
(Pdisniff), and the best of three efforts was considered for
data analysis.19 Dynamic intrinsic positive end-expiratory
pressure (PEEPidyn) was estimated from the decrease in
pleural pressure (Ppl) preceding the start of the inspiratory
flow and was corrected for the activity of the expiratory
muscles by subtracting the negative deflection of the abdom-
inal pressure (Pab).6 For more details about physiological
measurements, see Supplemental Materials.
Statistical Analysis
The statistical package GraphPad Prism 7.0 (GraphPad
Software, Inc., La Jolla, CA, USA) was used for analysis.
The study population has been characterized through
descriptive statistics and data are presented as mean and
interquartile ranges for continuous variables, and as num-
bers and percentages for dichotomous variables. The asso-
ciation between Pdisniff values and static and dynamic
mechanical features was assessed through linear regression
analysis and Pearson’s correlation coefficient. The associa-
tion between Pdisniff and Pdi/Pdisniff was assessed
through linear regression analysis and Pearson’s correla-
tion coefficient. A p value lower than 0.05 was considered
significant.
Results
Demographics and relevant clinical features of the patients
on admission are shown in Table 1. All patients were
classified as COPD GOLD D20 according to clinical and
functional data.
Table 2 shows the physiological characteristics of each
of the enrolled patients. Of note, the average Pdisniff value
was 2.3 (standard deviation [SD]=29) cmH2O and three
patients presented bilateral diaphragm palsy. The average
EELV measured during controlled mechanical ventilation
and static intrinsic PEEP was 2900 (SD=975) mL and 8.8
(SD=5.7) cmH2O, respectively.
Dynamic intrinsic PEEP was considerably higher with
values ranging from 1 to 22 cmH2O. Analysis of the
mechanical properties of the respiratory system showed
low levels of lung elastance (average value 6.7 [SD=2.9]
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cmH2O/L) and high values of airway resistance (average
value 33 [SD=10.2] cmH2O/L*sec).
Linear regression analysis showed a high inverse correla-
tion between maximal diaphragmatic strength and dynamic
intrinsic PEEP (r=–0.73, p=0.007) (Figure 2, panel A) while
no significant correlation was found with static indices of
hyperinflation (static intrinsic PEEP r=–0.55, p=0.06, EELV
r=–0.4, p=0.3, respectively) and airway resistance (r=–0.2,
p=0.54) (Figure 3, panel A and D). A high direct correlation
was found between Pdisniff values and static lung elastance
(r=0.69, p=0.01) (Figure 2, panel B) while no correlation was
demonstrated between Pdisniff values and either total ela-
stance or chest wall elastance (r=0.3, p=0.36 and r=−0.01,
p=0.96, respectively) (Figure 3, panel B and C). A significant
linear inverse correlation was found between Pdi/Pdisniff
and Pdisniff (r=–0.88, p=0.001, Figure 2, panel C).
Discussion
With this prospective physiological study, we have shown
that COPD patients who fail NIV have a marked diaphrag-
matic dysfunction that can even lead to muscle paralysis.
The maximal contraction force generated by the dia-
phragm is mainly influenced by mechanical factors,
while metabolic- and infection-related alterations are prob-
ably less relevant in this subset of patients. In particular,
the linear correlation between static elastance and max-
imum contraction force of the diaphragm suggests that
high elasticity of the lung at baseline constitutes
Table 1 Demographics and Relevant Clinical Features of the
Patients On Admission
Feature Value
Patients (n) 12
Age (years) 69 (8.4)
Male (n) 9 (75%)
Pneumonia (n) 6 (50%)
Diabetes (n) 6 (50%)
GCS 12 (3.4)
APACHE II 27 (6.5)
SAPS II 46 (6.3)
SOFA 6.1 (2.1)
pH 7.21 (0.06)
pCO2 (mmHg) 88 (10.3)
Blood lactate (mg/dL) 9 (4.5)
P/F 168 (20.4)
Note: Data are presented as number and percentage for dichotomous values or
mean value and standard deviation for continuous values.
Abbreviations: APACHE II, Acute Physiology and Chronic Health Evaluation II;
GCS, Glasgow Coma Scale; P/F, PaO2/FiO2 ratio; SAPS, Simplified Acute Physiology
Score; SOFA, Subsequent Organ Failure Assessment.
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a susceptibility factor to the development of diaphragmatic
dysfunction during AECOPD. Moreover, the inverse cor-
relation between PEEPidyn and Pdisniff (Figure 2A) sug-
gests that dynamic hyperinflation is the main physiological
mechanism which, acting on a predisposing mechanical
substrate, determines diaphragmatic dysfunction during
spontaneous breathing in severe AECOPD requiring NIV.
Therefore, the results of this study allow us to speculate
the existence of a physiological phenotype of COPD prone
to NIV failure, which is characterized by high elastic
properties of the lung at baseline that make it susceptible
to a higher volume overload during dynamic
hyperinflation.
Maximal Transdiaphragmatic Pressure in
AECOPD Patients Who Experience NIV
Failure
There are only a few studies evaluating the maximum
contraction force generated by the diaphragm during
AECOPD. In a recent study, Ceriana et al evaluated
changes in respiratory mechanics and diaphragmatic
contractile force in a cohort of COPD patients during
severe exacerbation requiring NIV and during the
“recovery” period.8 The maximal contractile capacity
of the diaphragm, measured with the Pdisniff technique,
was significantly reduced in the AECOPD period com-
pared to the measurements performed during clinical
stability. In this study, the mean Pdisniff during
AECOPD treated with NIV was 43 cmH2O, a value
that is about twice that which we recorded in our series.
In another study, Purro et al showed an increase in load
associated with respiratory muscle weakness during the
early phase of AECOPD resulting in a load/capacity
imbalance.9 Nine patients required ventilator support
because of acute respiratory acidosis due to AECOPD
(NPPV group), while seven patients were successfully
managed with medical therapy alone (SB group). In that
study, the data collected showed that the maximal
Figure 2 (A) Linear regression analysis showing correlation between dynamic intrinsic PEEP and maximal transdiaphragmatic pressure. (B) Linear regression analysis
showing correlation between static lung elastance and maximal transdiaphragmatic pressure. (C) Linear regression analysis showing inverse correlation between Pdi/Pdisniff
and Pdisniff.
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transdiaphragmatic pressure (Pdimax) generated was
significantly lower in patients with more severe
AECOPD requiring ventilatory support (NPPV group,
Pdimax: 40.1 cmH2O) than in patients treated with
medical therapy alone (SB group, Pdimax: 68.9 cmH2
O). In our series, Pdisniff was significantly lower than
in patients enrolled in other studies evaluating the
AECOPD phase. These data indicate that AECOPD
patients who experience NIV failure may have more
severe diaphragmatic impairment, which might differ-
entiate them from patients with AECOPD successfully
managed with NIV. In support of this hypothesis is the
finding of three patients with bilateral diaphragmatic
paralysis in our series.
Finally, the linear correlation between Pdisniff and Pdi/
Pdisniff suggests that muscle dysfunction might be con-
sidered to be a critical factor affecting the load/capacity
imbalance.
EELV and Maximal Transdiaphragmatic
Pressure
As already known, the contractile capacity of the dia-
phragm is closely related to the length–tension relationship
of the muscle. Some experimental studies have shown that
the active tension developed by the muscle during contrac-
tion is a function of the rest length of the muscle before
stimulation.21–23 Being the length of the diaphragm influ-
enced by lung volume, lung hyperinflation is one of the
main determinants of the ability of the muscle to generate
pressure.24–26 Moreover, several studies have shown how
the flattening and shortening of the diaphragm can result in
a structural modification of muscle fibers after a variable
time. Indeed, the mechanical disadvantage of the dia-
phragm produced by hyperinflation determines the imple-
mentation of adaptation mechanisms designed to restore
the optimal muscle length.27 This structural alteration is an
adaptive mechanism that partly allows conservation of the
Figure 3 (A) Linear regression analysis showing correlation between static intrinsic PEEP and maximal transdiaphragmatic pressure. (B) Linear regression analysis showing
correlation between static elastance of the respiratory system and maximal transdiaphragmatic pressure. (C) Linear regression analysis showing correlation between chest wall
elastance and maximal transdiaphragmatic pressure. (D) Linear regression analysis showing correlation between airway resistance and maximal transdiaphragmatic pressure.
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diaphragm’s ability to generate force.28 More recently,
Lindqvist et al have shown that mechanical ventilation
with PEEP determines similar adaptive mechanisms by
reducing the number of sarcomeres in series in whole-
length diaphragm fibers, suggesting that this mechanism
could contribute to the rapid development of diaphragm
weakness in critically ill patients.29,30
Since lung volume is the “critical factor” for diaphragm
contractile capacity, in our series, we have analyzed EELV
and correlated it with patient-generated Pdisniff. The mean
measured EELV was 2900 mL (Table 2), which is quite
similar to previous assessments that were performed in
heterogeneous populations undergoing invasive mechanical
ventilation.31,32 The EELV measured in our COPD popula-
tion might seem to be not as high as one would expect, but
we must consider that most of the studies that analyzed the
EELV used different methodologies and the measurements
were performed after PEEP application.16,33 In our protocol,
the measurement of EELV was performed at ZEEP during
controlled mechanical ventilation, so the lung volume
obtained may not be comparable with that measured in
other studies. Furthermore, the results of our study do not
show a significant correlation between baseline EELV and
maximal contractile capacity of the diaphragm measured by
the sniff maneuver. This result can be explained by various
considerations. First, the measured lung volume may be
underestimated and may not accurately represent static
hyperinflation, due to various factors: (1) the presence of
derecruitment phenomena of the lung-dependent areas dur-
ing controlled ventilation and ZEEP, (2) reduction of about
25% of the EELV in the semi-supine position with respect
to the volume that can be measured in orthostatism.34
Second, the ventilatory strategy and the pharmacological
approach might be able to empty the lung. For this reason,
the lung volume measured during controlled ventilation
might represent static hyperinflation, but it does not corre-
spond to the lung volume achieved during the spontaneous
breathing trial, which is subject to dynamic hyperinflation.
The difficulty in obtaining reliable values of EELV during
the spontaneous breathing trial limits the conclusions of our
study, but it is likely that the volume achieved during
dynamic hyperinflation is the key factor influencing dia-
phragmatic contractility for at least two reasons: (1) volume
overload during dynamic hyperinflation could reach an area
very close to total lung capacity (TLC) with severe short-
ening of diaphragmatic fibers; (2) acute volume overload
does not allow the establishment of the compensating
molecular phenomena that serve to maintain the contractile
capacity of the muscle.
Respiratory Mechanics and Contractile
Capacity of the Diaphragm
One of the study’s most important findings is the significant
linear correlation between lung static elastance and Pdisniff.
These data may not seem easy to interpret, and this therefore
requires some consideration. During AECOPD, dynamic
hyperinflation shifts the patient’s tidal volume to an area of
the pressure–volume curve where the lung is less distensible,
resulting in an increase in dynamic lung elastance and elastic
load.35 Along with the increased resistive load, this can con-
tribute to determine the imbalance between respiratory muscle
effort and load that occurs when hypercapnic respiratory fail-
ure develops. Measurement of static lung elastance during
controlled mechanical ventilation does not correspond to
dynamic lung elastance that the patient develops in sponta-
neous breathing during AECOPD, but it describes the lung
elastic condition at baseline. This consideration has some
relevance; indeed, it can be deduced that the lung static ela-
stance can be considered to be the measure of how much the
lung is susceptible to volume overload during dynamic hyper-
inflation. Patients with very low lung elastance at baseline will
develop a noticeable increase in end-expiratory volume once
PEEPdyn is applied. Considerable volume overload will result
in a rapid significant shortening of diaphragmatic fibers with
the consequences already discussed on muscle strength. The
static lung elastance measured in our series is lower than that
measured in other studies that evaluated small COPD popula-
tions. Ranieri et al performed measurements of static respira-
tory mechanics at various PEEP levels (from ZEEP to 15
cmH2O) in 7 COPD patients undergoing mechanical
ventilation.36 The mean lung elastance at ZEEP was 9.8
cmH2O/L, significantly higher than that detected in our
patients (6.7 cmH2O/L). A subsequent study compared the
static respiratory mechanics of 8 mechanically ventilated
AECOPD patients with 9 patients without pulmonary disease
who underwent mechanical ventilation for surgical reasons.37
The mean lung static elastance in COPD patients was 9.2
cmH2O/L and did not differ significantly from that measured
in surgical patients. These data indicate that patients enrolled
in our study have a severe alteration of lung elasticity, as
shown by the values of static lung elastance definitely lower
than those measured in previous studies. Another result of our
study is the significant inverse correlation between PEEPdyn
and Pdisniff during the spontaneous breathing trial. This
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correlation is easily understandable and confirms that dynamic
hyperinflation is one of the most important physiological
phenomena that limits the contractile capacity of the dia-
phragm during AECOPD. Therefore, by evaluating these phy-
siological data as a whole, we can hypothesize that the portion
of AECOPD patients who fail NIV constitute a “physiological
phenotype” characterized by low lung elastance at baseline
over which dynamic hyperinflation is superimposed. The
result is a significant volume overload with shortening of the
diaphragm and consequent muscle dysfunction.
Limitations of the Study
This prospective physiological study presents some metho-
dological limitations that must be highlighted. First, the
limited number of patients enrolled raises concerns about
the statistical appropriateness of linear regression on out-
comes assessment. Given the physiological nature of the
study, the regression model can reasonably be used to pro-
duce estimates that may be considered quite stable despite
outliers.38 These estimates need to be confirmed by larger
clinical trials. Second, diaphragm maximal force was mea-
sured by a volitional test (Pdisniff) in intubated patients at the
end of the spontaneous breathing trial. Although we per-
formed a rigorous selection of patients and verified the relia-
bility of the results of the Pdisniff maneuvers performed,
a non-volitional test carried out with magnetic or electrical
stimulation of the phrenic nerve could prove to be more
accurate. Third, due to technical difficulties, it was not pos-
sible to measure the EELV reached at the end of the sponta-
neous breathing trial; therefore, it is not possible to know the
EELV reached at the time of Pdisniff measurement.
Moreover, in a population of patients with severe COPD,
the EELVas assessed by nitrogen washout/washin technique
might result quite inaccurate due to close volume.
Considering this limitation, we do not know the volume
overload due to dynamic hyperinflation; therefore, the effect
of PEEPdyn and lung static elastance on lung volume at the
end of the spontaneous breathing trial remains speculative.
Conclusions
With this prospective physiological study, we have shown that
AECOPD patients who have experienced NIV failure present
with severe diaphragmatic dysfunction that can lead to muscle
paralysis. The causes of extreme diaphragmatic weakness
might be probably predominantly mechanical, determined by
a severe dynamic hyperinflation that overlaps on an elastic
substrate of the lung favoring volume overload. The results
of the study might suggest the existence of a physiological
phenotype of AECOPD prone to NIV failure, characterized by
low lung elastance and development of high values of
PEEPdyn during acute exacerbation. Despite its obvious lim-
itations, we believe that this study can increase our under-
standing of the complex physiological mechanisms
underlying NIV failure in AECOPD.
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